nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—CYP3A5—prostate cancer	0.174	0.473	CbGaD
Oxcarbazepine—CYP2C19—prostate cancer	0.119	0.322	CbGaD
Oxcarbazepine—CYP3A4—prostate cancer	0.0755	0.205	CbGaD
Oxcarbazepine—ALB—Abiraterone—prostate cancer	0.0357	0.0875	CbGbCtD
Oxcarbazepine—CYP3A5—Flutamide—prostate cancer	0.0287	0.0703	CbGbCtD
Oxcarbazepine—CYP2C19—Nilutamide—prostate cancer	0.0279	0.0685	CbGbCtD
Oxcarbazepine—CYP2C19—Bicalutamide—prostate cancer	0.0279	0.0685	CbGbCtD
Oxcarbazepine—ALB—Estrone—prostate cancer	0.0258	0.0633	CbGbCtD
Oxcarbazepine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0257	0.063	CbGbCtD
Oxcarbazepine—CYP2C19—Flutamide—prostate cancer	0.0231	0.0567	CbGbCtD
Oxcarbazepine—CYP3A5—Cabazitaxel—prostate cancer	0.0212	0.052	CbGbCtD
Oxcarbazepine—CYP3A5—Estrone—prostate cancer	0.0207	0.0509	CbGbCtD
Oxcarbazepine—ALB—Estradiol—prostate cancer	0.0148	0.0363	CbGbCtD
Oxcarbazepine—CYP3A4—Bicalutamide—prostate cancer	0.0135	0.0331	CbGbCtD
Oxcarbazepine—ALB—Prednisone—prostate cancer	0.0127	0.0313	CbGbCtD
Oxcarbazepine—CYP3A4—Estramustine—prostate cancer	0.0125	0.0308	CbGbCtD
Oxcarbazepine—CYP3A5—Estradiol—prostate cancer	0.0119	0.0292	CbGbCtD
Oxcarbazepine—CYP3A4—Flutamide—prostate cancer	0.0112	0.0274	CbGbCtD
Oxcarbazepine—CYP3A4—Abiraterone—prostate cancer	0.0112	0.0274	CbGbCtD
Oxcarbazepine—CYP2C19—Estradiol—prostate cancer	0.0096	0.0236	CbGbCtD
Oxcarbazepine—CYP3A4—Cabazitaxel—prostate cancer	0.00827	0.0203	CbGbCtD
Oxcarbazepine—CYP2C19—Prednisone—prostate cancer	0.00826	0.0203	CbGbCtD
Oxcarbazepine—CYP3A4—Estrone—prostate cancer	0.00808	0.0198	CbGbCtD
Oxcarbazepine—CYP3A5—Etoposide—prostate cancer	0.00777	0.0191	CbGbCtD
Oxcarbazepine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0072	0.0177	CbGbCtD
Oxcarbazepine—CYP3A5—Docetaxel—prostate cancer	0.00711	0.0175	CbGbCtD
Oxcarbazepine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00529	0.013	CbGbCtD
Oxcarbazepine—CYP3A4—Mitoxantrone—prostate cancer	0.00481	0.0118	CbGbCtD
Oxcarbazepine—CYP3A4—Estradiol—prostate cancer	0.00464	0.0114	CbGbCtD
Oxcarbazepine—CYP3A4—Prednisone—prostate cancer	0.00399	0.00979	CbGbCtD
Oxcarbazepine—CYP3A4—Etoposide—prostate cancer	0.00303	0.00744	CbGbCtD
Oxcarbazepine—CYP3A4—Docetaxel—prostate cancer	0.00277	0.0068	CbGbCtD
Oxcarbazepine—CYP3A4—Doxorubicin—prostate cancer	0.00207	0.00507	CbGbCtD
Oxcarbazepine—Dimetacrine—ACHE—prostate cancer	0.000288	0.0873	CrCbGaD
Oxcarbazepine—Carbamazepine—RALBP1—prostate cancer	0.000277	0.0841	CrCbGaD
Oxcarbazepine—Warfarin—CYP2C18—prostate cancer	0.000152	0.0461	CrCbGaD
Oxcarbazepine—Clobazam—CYP2C18—prostate cancer	0.000121	0.0367	CrCbGaD
Oxcarbazepine—Desipramine—SLC22A3—prostate cancer	8.77e-05	0.0266	CrCbGaD
Oxcarbazepine—Modafinil—CYP3A5—prostate cancer	8.2e-05	0.0249	CrCbGaD
Oxcarbazepine—Nepafenac—PTGS2—prostate cancer	8.07e-05	0.0245	CrCbGaD
Oxcarbazepine—Magnesium salicylate—PTGS2—prostate cancer	7.89e-05	0.0239	CrCbGaD
Oxcarbazepine—Desipramine—CYP2C18—prostate cancer	7.7e-05	0.0233	CrCbGaD
Oxcarbazepine—Piroxicam—PTGS2—prostate cancer	7.57e-05	0.0229	CrCbGaD
Oxcarbazepine—Carbamazepine—CYP3A5—prostate cancer	7.48e-05	0.0227	CrCbGaD
Oxcarbazepine—Imipramine—SLC22A3—prostate cancer	7.43e-05	0.0225	CrCbGaD
Oxcarbazepine—Diazepam—CYP2C18—prostate cancer	7.07e-05	0.0214	CrCbGaD
Oxcarbazepine—Warfarin—CYP2C19—prostate cancer	6.81e-05	0.0207	CrCbGaD
Oxcarbazepine—Indapamide—CYP3A4—prostate cancer	6.8e-05	0.0206	CrCbGaD
Oxcarbazepine—Warfarin—CYP1A1—prostate cancer	6.79e-05	0.0206	CrCbGaD
Oxcarbazepine—Salsalate—PTGS2—prostate cancer	6.71e-05	0.0203	CrCbGaD
Oxcarbazepine—Imipramine—CYP2C18—prostate cancer	6.53e-05	0.0198	CrCbGaD
Oxcarbazepine—Desipramine—SLC22A1—prostate cancer	6.29e-05	0.0191	CrCbGaD
Oxcarbazepine—Nortriptyline—CYP3A5—prostate cancer	6.16e-05	0.0187	CrCbGaD
Oxcarbazepine—Alimemazine—CYP3A4—prostate cancer	5.64e-05	0.0171	CrCbGaD
Oxcarbazepine—Modafinil—CYP2C19—prostate cancer	5.58e-05	0.0169	CrCbGaD
Oxcarbazepine—Clobazam—CYP2C19—prostate cancer	5.43e-05	0.0165	CrCbGaD
Oxcarbazepine—Imipramine—SLC22A1—prostate cancer	5.33e-05	0.0162	CrCbGaD
Oxcarbazepine—Epinastine—CYP3A4—prostate cancer	5.16e-05	0.0156	CrCbGaD
Oxcarbazepine—Carbamazepine—CYP2C19—prostate cancer	5.09e-05	0.0154	CrCbGaD
Oxcarbazepine—Desipramine—CYP2A6—prostate cancer	4.91e-05	0.0149	CrCbGaD
Oxcarbazepine—Diazepam—CYP3A5—prostate cancer	4.66e-05	0.0141	CrCbGaD
Oxcarbazepine—Warfarin—CYP3A4—prostate cancer	4.33e-05	0.0131	CrCbGaD
Oxcarbazepine—Amitriptyline—CYP3A5—prostate cancer	4.27e-05	0.013	CrCbGaD
Oxcarbazepine—Nortriptyline—CYP2E1—prostate cancer	4.23e-05	0.0128	CrCbGaD
Oxcarbazepine—Nortriptyline—CYP2C19—prostate cancer	4.19e-05	0.0127	CrCbGaD
Oxcarbazepine—Desipramine—ADRB2—prostate cancer	4.01e-05	0.0122	CrCbGaD
Oxcarbazepine—Trimipramine—CYP2C19—prostate cancer	3.95e-05	0.012	CrCbGaD
Oxcarbazepine—Doxepin—CYP2C19—prostate cancer	3.76e-05	0.0114	CrCbGaD
Oxcarbazepine—Modafinil—CYP3A4—prostate cancer	3.55e-05	0.0108	CrCbGaD
Oxcarbazepine—Desipramine—CYP2E1—prostate cancer	3.49e-05	0.0106	CrCbGaD
Oxcarbazepine—Desipramine—CYP2C19—prostate cancer	3.45e-05	0.0105	CrCbGaD
Oxcarbazepine—Clobazam—CYP3A4—prostate cancer	3.45e-05	0.0105	CrCbGaD
Oxcarbazepine—Promazine—CYP2C19—prostate cancer	3.34e-05	0.0101	CrCbGaD
Oxcarbazepine—Carbamazepine—CYP3A4—prostate cancer	3.24e-05	0.00982	CrCbGaD
Oxcarbazepine—Diazepam—CYP2E1—prostate cancer	3.2e-05	0.0097	CrCbGaD
Oxcarbazepine—Diazepam—CYP2C19—prostate cancer	3.17e-05	0.00961	CrCbGaD
Oxcarbazepine—Mianserin—CYP3A4—prostate cancer	2.98e-05	0.00904	CrCbGaD
Oxcarbazepine—Imipramine—CYP2E1—prostate cancer	2.96e-05	0.00896	CrCbGaD
Oxcarbazepine—Amitriptyline—CYP2E1—prostate cancer	2.94e-05	0.00891	CrCbGaD
Oxcarbazepine—Imipramine—CYP2C19—prostate cancer	2.93e-05	0.00888	CrCbGaD
Oxcarbazepine—Amitriptyline—CYP2C19—prostate cancer	2.91e-05	0.00882	CrCbGaD
Oxcarbazepine—Nortriptyline—CYP3A4—prostate cancer	2.67e-05	0.00808	CrCbGaD
Oxcarbazepine—Agranulocytosis—Doxorubicin—prostate cancer	2.61e-05	0.000163	CcSEcCtD
Oxcarbazepine—Hypertension—Prednisone—prostate cancer	2.6e-05	0.000163	CcSEcCtD
Oxcarbazepine—Rash—Mitoxantrone—prostate cancer	2.6e-05	0.000163	CcSEcCtD
Oxcarbazepine—Dermatitis—Mitoxantrone—prostate cancer	2.6e-05	0.000163	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.6e-05	0.000163	CcSEcCtD
Oxcarbazepine—Headache—Mitoxantrone—prostate cancer	2.59e-05	0.000162	CcSEcCtD
Oxcarbazepine—Hypotension—Capecitabine—prostate cancer	2.58e-05	0.000162	CcSEcCtD
Oxcarbazepine—Insomnia—Docetaxel—prostate cancer	2.58e-05	0.000162	CcSEcCtD
Oxcarbazepine—Myalgia—Prednisone—prostate cancer	2.57e-05	0.000161	CcSEcCtD
Oxcarbazepine—Arthralgia—Prednisone—prostate cancer	2.57e-05	0.000161	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Epirubicin—prostate cancer	2.56e-05	0.000161	CcSEcCtD
Oxcarbazepine—Anxiety—Prednisone—prostate cancer	2.56e-05	0.00016	CcSEcCtD
Oxcarbazepine—Bradycardia—Doxorubicin—prostate cancer	2.55e-05	0.00016	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.55e-05	0.00016	CcSEcCtD
Oxcarbazepine—Dyspnoea—Docetaxel—prostate cancer	2.54e-05	0.000159	CcSEcCtD
Oxcarbazepine—Somnolence—Docetaxel—prostate cancer	2.54e-05	0.000159	CcSEcCtD
Oxcarbazepine—Discomfort—Prednisone—prostate cancer	2.54e-05	0.000159	CcSEcCtD
Oxcarbazepine—Eye disorder—Epirubicin—prostate cancer	2.53e-05	0.000159	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Etoposide—prostate cancer	2.53e-05	0.000159	CcSEcCtD
Oxcarbazepine—Tinnitus—Epirubicin—prostate cancer	2.53e-05	0.000158	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.52e-05	0.000158	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Epirubicin—prostate cancer	2.51e-05	0.000158	CcSEcCtD
Oxcarbazepine—Flushing—Epirubicin—prostate cancer	2.51e-05	0.000158	CcSEcCtD
Oxcarbazepine—Rhinitis—Doxorubicin—prostate cancer	2.51e-05	0.000157	CcSEcCtD
Oxcarbazepine—Dyspepsia—Docetaxel—prostate cancer	2.51e-05	0.000157	CcSEcCtD
Oxcarbazepine—Trimipramine—CYP3A4—prostate cancer	2.51e-05	0.00761	CrCbGaD
Oxcarbazepine—Hepatitis—Doxorubicin—prostate cancer	2.51e-05	0.000157	CcSEcCtD
Oxcarbazepine—Insomnia—Capecitabine—prostate cancer	2.5e-05	0.000157	CcSEcCtD
Oxcarbazepine—Hypoaesthesia—Doxorubicin—prostate cancer	2.49e-05	0.000156	CcSEcCtD
Oxcarbazepine—Pharyngitis—Doxorubicin—prostate cancer	2.49e-05	0.000156	CcSEcCtD
Oxcarbazepine—Decreased appetite—Docetaxel—prostate cancer	2.48e-05	0.000155	CcSEcCtD
Oxcarbazepine—Oedema peripheral—Doxorubicin—prostate cancer	2.47e-05	0.000155	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Docetaxel—prostate cancer	2.46e-05	0.000154	CcSEcCtD
Oxcarbazepine—Asthenia—Etoposide—prostate cancer	2.46e-05	0.000154	CcSEcCtD
Oxcarbazepine—Dyspnoea—Capecitabine—prostate cancer	2.46e-05	0.000154	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Prednisone—prostate cancer	2.46e-05	0.000154	CcSEcCtD
Oxcarbazepine—Fatigue—Docetaxel—prostate cancer	2.46e-05	0.000154	CcSEcCtD
Oxcarbazepine—Angiopathy—Epirubicin—prostate cancer	2.46e-05	0.000154	CcSEcCtD
Oxcarbazepine—Nausea—Mitoxantrone—prostate cancer	2.45e-05	0.000154	CcSEcCtD
Oxcarbazepine—Immune system disorder—Epirubicin—prostate cancer	2.45e-05	0.000153	CcSEcCtD
Oxcarbazepine—Infection—Prednisone—prostate cancer	2.44e-05	0.000153	CcSEcCtD
Oxcarbazepine—Pain—Docetaxel—prostate cancer	2.44e-05	0.000153	CcSEcCtD
Oxcarbazepine—Constipation—Docetaxel—prostate cancer	2.44e-05	0.000153	CcSEcCtD
Oxcarbazepine—Dyspepsia—Capecitabine—prostate cancer	2.43e-05	0.000152	CcSEcCtD
Oxcarbazepine—Chills—Epirubicin—prostate cancer	2.43e-05	0.000152	CcSEcCtD
Oxcarbazepine—Pruritus—Etoposide—prostate cancer	2.43e-05	0.000152	CcSEcCtD
Oxcarbazepine—Shock—Prednisone—prostate cancer	2.42e-05	0.000152	CcSEcCtD
Oxcarbazepine—Arrhythmia—Epirubicin—prostate cancer	2.42e-05	0.000152	CcSEcCtD
Oxcarbazepine—Visual impairment—Doxorubicin—prostate cancer	2.42e-05	0.000151	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Prednisone—prostate cancer	2.41e-05	0.000151	CcSEcCtD
Oxcarbazepine—Tachycardia—Prednisone—prostate cancer	2.4e-05	0.000151	CcSEcCtD
Oxcarbazepine—Decreased appetite—Capecitabine—prostate cancer	2.4e-05	0.000151	CcSEcCtD
Oxcarbazepine—Alopecia—Epirubicin—prostate cancer	2.39e-05	0.00015	CcSEcCtD
Oxcarbazepine—Doxepin—CYP3A4—prostate cancer	2.39e-05	0.00725	CrCbGaD
Oxcarbazepine—Skin disorder—Prednisone—prostate cancer	2.39e-05	0.00015	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Capecitabine—prostate cancer	2.38e-05	0.000149	CcSEcCtD
Oxcarbazepine—Fatigue—Capecitabine—prostate cancer	2.38e-05	0.000149	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Prednisone—prostate cancer	2.38e-05	0.000149	CcSEcCtD
Oxcarbazepine—Mental disorder—Epirubicin—prostate cancer	2.37e-05	0.000149	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Doxorubicin—prostate cancer	2.37e-05	0.000149	CcSEcCtD
Oxcarbazepine—Constipation—Capecitabine—prostate cancer	2.36e-05	0.000148	CcSEcCtD
Oxcarbazepine—Pain—Capecitabine—prostate cancer	2.36e-05	0.000148	CcSEcCtD
Oxcarbazepine—Malnutrition—Epirubicin—prostate cancer	2.36e-05	0.000148	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Docetaxel—prostate cancer	2.35e-05	0.000147	CcSEcCtD
Oxcarbazepine—Diarrhoea—Etoposide—prostate cancer	2.35e-05	0.000147	CcSEcCtD
Oxcarbazepine—Anorexia—Prednisone—prostate cancer	2.35e-05	0.000147	CcSEcCtD
Oxcarbazepine—Eye disorder—Doxorubicin—prostate cancer	2.34e-05	0.000147	CcSEcCtD
Oxcarbazepine—Tinnitus—Doxorubicin—prostate cancer	2.34e-05	0.000146	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Docetaxel—prostate cancer	2.33e-05	0.000146	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Doxorubicin—prostate cancer	2.33e-05	0.000146	CcSEcCtD
Oxcarbazepine—Flushing—Doxorubicin—prostate cancer	2.33e-05	0.000146	CcSEcCtD
Oxcarbazepine—Flatulence—Epirubicin—prostate cancer	2.32e-05	0.000146	CcSEcCtD
Oxcarbazepine—Tension—Epirubicin—prostate cancer	2.31e-05	0.000145	CcSEcCtD
Oxcarbazepine—Dysgeusia—Epirubicin—prostate cancer	2.31e-05	0.000145	CcSEcCtD
Oxcarbazepine—Nervousness—Epirubicin—prostate cancer	2.29e-05	0.000144	CcSEcCtD
Oxcarbazepine—Back pain—Epirubicin—prostate cancer	2.28e-05	0.000143	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Capecitabine—prostate cancer	2.28e-05	0.000143	CcSEcCtD
Oxcarbazepine—Angiopathy—Doxorubicin—prostate cancer	2.27e-05	0.000143	CcSEcCtD
Oxcarbazepine—Dizziness—Etoposide—prostate cancer	2.27e-05	0.000142	CcSEcCtD
Oxcarbazepine—Immune system disorder—Doxorubicin—prostate cancer	2.26e-05	0.000142	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Capecitabine—prostate cancer	2.26e-05	0.000142	CcSEcCtD
Oxcarbazepine—Abdominal pain—Docetaxel—prostate cancer	2.26e-05	0.000141	CcSEcCtD
Oxcarbazepine—Body temperature increased—Docetaxel—prostate cancer	2.26e-05	0.000141	CcSEcCtD
Oxcarbazepine—Chills—Doxorubicin—prostate cancer	2.25e-05	0.000141	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Prednisone—prostate cancer	2.24e-05	0.000141	CcSEcCtD
Oxcarbazepine—Arrhythmia—Doxorubicin—prostate cancer	2.24e-05	0.00014	CcSEcCtD
Oxcarbazepine—Insomnia—Prednisone—prostate cancer	2.23e-05	0.000139	CcSEcCtD
Oxcarbazepine—Vision blurred—Epirubicin—prostate cancer	2.22e-05	0.000139	CcSEcCtD
Oxcarbazepine—Alopecia—Doxorubicin—prostate cancer	2.21e-05	0.000139	CcSEcCtD
Oxcarbazepine—Mental disorder—Doxorubicin—prostate cancer	2.2e-05	0.000138	CcSEcCtD
Oxcarbazepine—Desipramine—CYP3A4—prostate cancer	2.2e-05	0.00665	CrCbGaD
Oxcarbazepine—Urticaria—Capecitabine—prostate cancer	2.19e-05	0.000138	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Epirubicin—prostate cancer	2.19e-05	0.000137	CcSEcCtD
Oxcarbazepine—Body temperature increased—Capecitabine—prostate cancer	2.18e-05	0.000137	CcSEcCtD
Oxcarbazepine—Abdominal pain—Capecitabine—prostate cancer	2.18e-05	0.000137	CcSEcCtD
Oxcarbazepine—Vomiting—Etoposide—prostate cancer	2.18e-05	0.000137	CcSEcCtD
Oxcarbazepine—Malnutrition—Doxorubicin—prostate cancer	2.18e-05	0.000137	CcSEcCtD
Oxcarbazepine—Agitation—Epirubicin—prostate cancer	2.17e-05	0.000136	CcSEcCtD
Oxcarbazepine—Dyspepsia—Prednisone—prostate cancer	2.17e-05	0.000136	CcSEcCtD
Oxcarbazepine—Rash—Etoposide—prostate cancer	2.16e-05	0.000136	CcSEcCtD
Oxcarbazepine—Dermatitis—Etoposide—prostate cancer	2.16e-05	0.000136	CcSEcCtD
Oxcarbazepine—Headache—Etoposide—prostate cancer	2.15e-05	0.000135	CcSEcCtD
Oxcarbazepine—Flatulence—Doxorubicin—prostate cancer	2.15e-05	0.000135	CcSEcCtD
Oxcarbazepine—Tension—Doxorubicin—prostate cancer	2.14e-05	0.000134	CcSEcCtD
Oxcarbazepine—Decreased appetite—Prednisone—prostate cancer	2.14e-05	0.000134	CcSEcCtD
Oxcarbazepine—Dysgeusia—Doxorubicin—prostate cancer	2.14e-05	0.000134	CcSEcCtD
Oxcarbazepine—Promazine—CYP3A4—prostate cancer	2.13e-05	0.00645	CrCbGaD
Oxcarbazepine—Malaise—Epirubicin—prostate cancer	2.13e-05	0.000133	CcSEcCtD
Oxcarbazepine—Fatigue—Prednisone—prostate cancer	2.12e-05	0.000133	CcSEcCtD
Oxcarbazepine—Nervousness—Doxorubicin—prostate cancer	2.12e-05	0.000133	CcSEcCtD
Oxcarbazepine—Vertigo—Epirubicin—prostate cancer	2.12e-05	0.000133	CcSEcCtD
Oxcarbazepine—Syncope—Epirubicin—prostate cancer	2.11e-05	0.000133	CcSEcCtD
Oxcarbazepine—Leukopenia—Epirubicin—prostate cancer	2.11e-05	0.000132	CcSEcCtD
Oxcarbazepine—Back pain—Doxorubicin—prostate cancer	2.11e-05	0.000132	CcSEcCtD
Oxcarbazepine—Constipation—Prednisone—prostate cancer	2.1e-05	0.000132	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Docetaxel—prostate cancer	2.1e-05	0.000132	CcSEcCtD
Oxcarbazepine—Palpitations—Epirubicin—prostate cancer	2.08e-05	0.000131	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Epirubicin—prostate cancer	2.07e-05	0.00013	CcSEcCtD
Oxcarbazepine—Cough—Epirubicin—prostate cancer	2.06e-05	0.000129	CcSEcCtD
Oxcarbazepine—Vision blurred—Doxorubicin—prostate cancer	2.06e-05	0.000129	CcSEcCtD
Oxcarbazepine—Asthenia—Docetaxel—prostate cancer	2.05e-05	0.000128	CcSEcCtD
Oxcarbazepine—Convulsion—Epirubicin—prostate cancer	2.04e-05	0.000128	CcSEcCtD
Oxcarbazepine—Nausea—Etoposide—prostate cancer	2.04e-05	0.000128	CcSEcCtD
Oxcarbazepine—Hypertension—Epirubicin—prostate cancer	2.04e-05	0.000128	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Capecitabine—prostate cancer	2.04e-05	0.000128	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Prednisone—prostate cancer	2.03e-05	0.000127	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Doxorubicin—prostate cancer	2.02e-05	0.000127	CcSEcCtD
Oxcarbazepine—Pruritus—Docetaxel—prostate cancer	2.02e-05	0.000127	CcSEcCtD
Oxcarbazepine—Diazepam—CYP3A4—prostate cancer	2.02e-05	0.00611	CrCbGaD
Oxcarbazepine—Gastrointestinal pain—Prednisone—prostate cancer	2.01e-05	0.000126	CcSEcCtD
Oxcarbazepine—Arthralgia—Epirubicin—prostate cancer	2.01e-05	0.000126	CcSEcCtD
Oxcarbazepine—Chest pain—Epirubicin—prostate cancer	2.01e-05	0.000126	CcSEcCtD
Oxcarbazepine—Myalgia—Epirubicin—prostate cancer	2.01e-05	0.000126	CcSEcCtD
Oxcarbazepine—Agitation—Doxorubicin—prostate cancer	2e-05	0.000126	CcSEcCtD
Oxcarbazepine—Anxiety—Epirubicin—prostate cancer	2e-05	0.000125	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.99e-05	0.000125	CcSEcCtD
Oxcarbazepine—Discomfort—Epirubicin—prostate cancer	1.98e-05	0.000124	CcSEcCtD
Oxcarbazepine—Asthenia—Capecitabine—prostate cancer	1.98e-05	0.000124	CcSEcCtD
Oxcarbazepine—Malaise—Doxorubicin—prostate cancer	1.97e-05	0.000123	CcSEcCtD
Oxcarbazepine—Dry mouth—Epirubicin—prostate cancer	1.96e-05	0.000123	CcSEcCtD
Oxcarbazepine—Vertigo—Doxorubicin—prostate cancer	1.96e-05	0.000123	CcSEcCtD
Oxcarbazepine—Syncope—Doxorubicin—prostate cancer	1.96e-05	0.000123	CcSEcCtD
Oxcarbazepine—Urticaria—Prednisone—prostate cancer	1.95e-05	0.000123	CcSEcCtD
Oxcarbazepine—Pruritus—Capecitabine—prostate cancer	1.95e-05	0.000122	CcSEcCtD
Oxcarbazepine—Leukopenia—Doxorubicin—prostate cancer	1.95e-05	0.000122	CcSEcCtD
Oxcarbazepine—Diarrhoea—Docetaxel—prostate cancer	1.95e-05	0.000122	CcSEcCtD
Oxcarbazepine—Body temperature increased—Prednisone—prostate cancer	1.95e-05	0.000122	CcSEcCtD
Oxcarbazepine—Abdominal pain—Prednisone—prostate cancer	1.95e-05	0.000122	CcSEcCtD
Oxcarbazepine—Confusional state—Epirubicin—prostate cancer	1.94e-05	0.000122	CcSEcCtD
Oxcarbazepine—Palpitations—Doxorubicin—prostate cancer	1.93e-05	0.000121	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Epirubicin—prostate cancer	1.92e-05	0.000121	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Doxorubicin—prostate cancer	1.92e-05	0.00012	CcSEcCtD
Oxcarbazepine—Infection—Epirubicin—prostate cancer	1.91e-05	0.00012	CcSEcCtD
Oxcarbazepine—Cough—Doxorubicin—prostate cancer	1.9e-05	0.000119	CcSEcCtD
Oxcarbazepine—Shock—Epirubicin—prostate cancer	1.89e-05	0.000119	CcSEcCtD
Oxcarbazepine—Convulsion—Doxorubicin—prostate cancer	1.89e-05	0.000118	CcSEcCtD
Oxcarbazepine—Diarrhoea—Capecitabine—prostate cancer	1.89e-05	0.000118	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Epirubicin—prostate cancer	1.89e-05	0.000118	CcSEcCtD
Oxcarbazepine—Dizziness—Docetaxel—prostate cancer	1.89e-05	0.000118	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Epirubicin—prostate cancer	1.88e-05	0.000118	CcSEcCtD
Oxcarbazepine—Hypertension—Doxorubicin—prostate cancer	1.88e-05	0.000118	CcSEcCtD
Oxcarbazepine—Tachycardia—Epirubicin—prostate cancer	1.88e-05	0.000118	CcSEcCtD
Oxcarbazepine—Skin disorder—Epirubicin—prostate cancer	1.87e-05	0.000117	CcSEcCtD
Oxcarbazepine—Imipramine—CYP3A4—prostate cancer	1.86e-05	0.00564	CrCbGaD
Oxcarbazepine—Hyperhidrosis—Epirubicin—prostate cancer	1.86e-05	0.000117	CcSEcCtD
Oxcarbazepine—Myalgia—Doxorubicin—prostate cancer	1.86e-05	0.000116	CcSEcCtD
Oxcarbazepine—Arthralgia—Doxorubicin—prostate cancer	1.86e-05	0.000116	CcSEcCtD
Oxcarbazepine—Chest pain—Doxorubicin—prostate cancer	1.86e-05	0.000116	CcSEcCtD
Oxcarbazepine—Anxiety—Doxorubicin—prostate cancer	1.85e-05	0.000116	CcSEcCtD
Oxcarbazepine—Amitriptyline—CYP3A4—prostate cancer	1.85e-05	0.00561	CrCbGaD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.84e-05	0.000116	CcSEcCtD
Oxcarbazepine—Discomfort—Doxorubicin—prostate cancer	1.84e-05	0.000115	CcSEcCtD
Oxcarbazepine—Anorexia—Epirubicin—prostate cancer	1.83e-05	0.000115	CcSEcCtD
Oxcarbazepine—Dizziness—Capecitabine—prostate cancer	1.83e-05	0.000114	CcSEcCtD
Oxcarbazepine—Dry mouth—Doxorubicin—prostate cancer	1.82e-05	0.000114	CcSEcCtD
Oxcarbazepine—Vomiting—Docetaxel—prostate cancer	1.81e-05	0.000114	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Prednisone—prostate cancer	1.81e-05	0.000114	CcSEcCtD
Oxcarbazepine—Rash—Docetaxel—prostate cancer	1.8e-05	0.000113	CcSEcCtD
Oxcarbazepine—Hypotension—Epirubicin—prostate cancer	1.8e-05	0.000113	CcSEcCtD
Oxcarbazepine—Dermatitis—Docetaxel—prostate cancer	1.8e-05	0.000113	CcSEcCtD
Oxcarbazepine—Confusional state—Doxorubicin—prostate cancer	1.8e-05	0.000113	CcSEcCtD
Oxcarbazepine—Headache—Docetaxel—prostate cancer	1.79e-05	0.000112	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Doxorubicin—prostate cancer	1.78e-05	0.000112	CcSEcCtD
Oxcarbazepine—Infection—Doxorubicin—prostate cancer	1.77e-05	0.000111	CcSEcCtD
Oxcarbazepine—Asthenia—Prednisone—prostate cancer	1.77e-05	0.000111	CcSEcCtD
Oxcarbazepine—Vomiting—Capecitabine—prostate cancer	1.76e-05	0.00011	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.75e-05	0.00011	CcSEcCtD
Oxcarbazepine—Shock—Doxorubicin—prostate cancer	1.75e-05	0.00011	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Doxorubicin—prostate cancer	1.75e-05	0.000109	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Doxorubicin—prostate cancer	1.74e-05	0.000109	CcSEcCtD
Oxcarbazepine—Rash—Capecitabine—prostate cancer	1.74e-05	0.000109	CcSEcCtD
Oxcarbazepine—Pruritus—Prednisone—prostate cancer	1.74e-05	0.000109	CcSEcCtD
Oxcarbazepine—Insomnia—Epirubicin—prostate cancer	1.74e-05	0.000109	CcSEcCtD
Oxcarbazepine—Dermatitis—Capecitabine—prostate cancer	1.74e-05	0.000109	CcSEcCtD
Oxcarbazepine—Tachycardia—Doxorubicin—prostate cancer	1.74e-05	0.000109	CcSEcCtD
Oxcarbazepine—Headache—Capecitabine—prostate cancer	1.73e-05	0.000108	CcSEcCtD
Oxcarbazepine—Skin disorder—Doxorubicin—prostate cancer	1.73e-05	0.000108	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Doxorubicin—prostate cancer	1.72e-05	0.000108	CcSEcCtD
Oxcarbazepine—Dyspnoea—Epirubicin—prostate cancer	1.72e-05	0.000108	CcSEcCtD
Oxcarbazepine—Somnolence—Epirubicin—prostate cancer	1.71e-05	0.000107	CcSEcCtD
Oxcarbazepine—Anorexia—Doxorubicin—prostate cancer	1.7e-05	0.000106	CcSEcCtD
Oxcarbazepine—Nausea—Docetaxel—prostate cancer	1.69e-05	0.000106	CcSEcCtD
Oxcarbazepine—Dyspepsia—Epirubicin—prostate cancer	1.69e-05	0.000106	CcSEcCtD
Oxcarbazepine—Diarrhoea—Prednisone—prostate cancer	1.68e-05	0.000106	CcSEcCtD
Oxcarbazepine—Decreased appetite—Epirubicin—prostate cancer	1.67e-05	0.000105	CcSEcCtD
Oxcarbazepine—Hypotension—Doxorubicin—prostate cancer	1.66e-05	0.000104	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Epirubicin—prostate cancer	1.66e-05	0.000104	CcSEcCtD
Oxcarbazepine—Fatigue—Epirubicin—prostate cancer	1.66e-05	0.000104	CcSEcCtD
Oxcarbazepine—Pain—Epirubicin—prostate cancer	1.65e-05	0.000103	CcSEcCtD
Oxcarbazepine—Constipation—Epirubicin—prostate cancer	1.65e-05	0.000103	CcSEcCtD
Oxcarbazepine—Nausea—Capecitabine—prostate cancer	1.64e-05	0.000103	CcSEcCtD
Oxcarbazepine—Dizziness—Prednisone—prostate cancer	1.63e-05	0.000102	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.62e-05	0.000102	CcSEcCtD
Oxcarbazepine—Insomnia—Doxorubicin—prostate cancer	1.61e-05	0.000101	CcSEcCtD
Oxcarbazepine—Dyspnoea—Doxorubicin—prostate cancer	1.59e-05	9.95e-05	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Epirubicin—prostate cancer	1.59e-05	9.94e-05	CcSEcCtD
Oxcarbazepine—Somnolence—Doxorubicin—prostate cancer	1.58e-05	9.92e-05	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Epirubicin—prostate cancer	1.57e-05	9.86e-05	CcSEcCtD
Oxcarbazepine—Dyspepsia—Doxorubicin—prostate cancer	1.57e-05	9.82e-05	CcSEcCtD
Oxcarbazepine—Vomiting—Prednisone—prostate cancer	1.56e-05	9.81e-05	CcSEcCtD
Oxcarbazepine—Rash—Prednisone—prostate cancer	1.55e-05	9.72e-05	CcSEcCtD
Oxcarbazepine—Dermatitis—Prednisone—prostate cancer	1.55e-05	9.71e-05	CcSEcCtD
Oxcarbazepine—Decreased appetite—Doxorubicin—prostate cancer	1.55e-05	9.7e-05	CcSEcCtD
Oxcarbazepine—Headache—Prednisone—prostate cancer	1.54e-05	9.66e-05	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.54e-05	9.63e-05	CcSEcCtD
Oxcarbazepine—Fatigue—Doxorubicin—prostate cancer	1.54e-05	9.62e-05	CcSEcCtD
Oxcarbazepine—Urticaria—Epirubicin—prostate cancer	1.53e-05	9.58e-05	CcSEcCtD
Oxcarbazepine—Pain—Doxorubicin—prostate cancer	1.52e-05	9.54e-05	CcSEcCtD
Oxcarbazepine—Constipation—Doxorubicin—prostate cancer	1.52e-05	9.54e-05	CcSEcCtD
Oxcarbazepine—Abdominal pain—Epirubicin—prostate cancer	1.52e-05	9.53e-05	CcSEcCtD
Oxcarbazepine—Body temperature increased—Epirubicin—prostate cancer	1.52e-05	9.53e-05	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Doxorubicin—prostate cancer	1.47e-05	9.2e-05	CcSEcCtD
Oxcarbazepine—Nausea—Prednisone—prostate cancer	1.46e-05	9.16e-05	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Doxorubicin—prostate cancer	1.46e-05	9.13e-05	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Epirubicin—prostate cancer	1.42e-05	8.89e-05	CcSEcCtD
Oxcarbazepine—Urticaria—Doxorubicin—prostate cancer	1.41e-05	8.87e-05	CcSEcCtD
Oxcarbazepine—Abdominal pain—Doxorubicin—prostate cancer	1.41e-05	8.82e-05	CcSEcCtD
Oxcarbazepine—Body temperature increased—Doxorubicin—prostate cancer	1.41e-05	8.82e-05	CcSEcCtD
Oxcarbazepine—Asthenia—Epirubicin—prostate cancer	1.38e-05	8.65e-05	CcSEcCtD
Oxcarbazepine—Pruritus—Epirubicin—prostate cancer	1.36e-05	8.53e-05	CcSEcCtD
Oxcarbazepine—Diarrhoea—Epirubicin—prostate cancer	1.32e-05	8.25e-05	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Doxorubicin—prostate cancer	1.31e-05	8.22e-05	CcSEcCtD
Oxcarbazepine—Asthenia—Doxorubicin—prostate cancer	1.28e-05	8.01e-05	CcSEcCtD
Oxcarbazepine—Dizziness—Epirubicin—prostate cancer	1.27e-05	7.98e-05	CcSEcCtD
Oxcarbazepine—Pruritus—Doxorubicin—prostate cancer	1.26e-05	7.9e-05	CcSEcCtD
Oxcarbazepine—Vomiting—Epirubicin—prostate cancer	1.22e-05	7.67e-05	CcSEcCtD
Oxcarbazepine—Diarrhoea—Doxorubicin—prostate cancer	1.22e-05	7.64e-05	CcSEcCtD
Oxcarbazepine—Rash—Epirubicin—prostate cancer	1.21e-05	7.6e-05	CcSEcCtD
Oxcarbazepine—Dermatitis—Epirubicin—prostate cancer	1.21e-05	7.6e-05	CcSEcCtD
Oxcarbazepine—Headache—Epirubicin—prostate cancer	1.21e-05	7.56e-05	CcSEcCtD
Oxcarbazepine—Dizziness—Doxorubicin—prostate cancer	1.18e-05	7.38e-05	CcSEcCtD
Oxcarbazepine—Nausea—Epirubicin—prostate cancer	1.14e-05	7.16e-05	CcSEcCtD
Oxcarbazepine—Vomiting—Doxorubicin—prostate cancer	1.13e-05	7.1e-05	CcSEcCtD
Oxcarbazepine—Rash—Doxorubicin—prostate cancer	1.12e-05	7.04e-05	CcSEcCtD
Oxcarbazepine—Dermatitis—Doxorubicin—prostate cancer	1.12e-05	7.03e-05	CcSEcCtD
Oxcarbazepine—Headache—Doxorubicin—prostate cancer	1.12e-05	6.99e-05	CcSEcCtD
Oxcarbazepine—Nausea—Doxorubicin—prostate cancer	1.06e-05	6.63e-05	CcSEcCtD
Oxcarbazepine—CYP2C19—Metabolism—NAT2—prostate cancer	6.92e-06	0.000113	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—HSD3B2—prostate cancer	6.92e-06	0.000113	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTO1—prostate cancer	6.92e-06	0.000113	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—EGF—prostate cancer	6.89e-06	0.000113	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SULT2A1—prostate cancer	6.87e-06	0.000113	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP2A6—prostate cancer	6.86e-06	0.000112	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—MED12—prostate cancer	6.76e-06	0.000111	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GNG5—prostate cancer	6.7e-06	0.00011	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—AKR1C3—prostate cancer	6.67e-06	0.000109	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	6.65e-06	0.000109	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PRKACB—prostate cancer	6.64e-06	0.000109	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP2C18—prostate cancer	6.63e-06	0.000109	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—LRP2—prostate cancer	6.63e-06	0.000109	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PLCB2—prostate cancer	6.63e-06	0.000109	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP17A1—prostate cancer	6.57e-06	0.000108	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—P4HB—prostate cancer	6.5e-06	0.000107	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—CREBBP—prostate cancer	6.46e-06	0.000106	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NCOA3—prostate cancer	6.46e-06	0.000106	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HPGD—prostate cancer	6.46e-06	0.000106	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—B4GALT4—prostate cancer	6.46e-06	0.000106	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IGF1—prostate cancer	6.38e-06	0.000105	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	6.35e-06	0.000104	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SLC22A1—prostate cancer	6.33e-06	0.000104	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	6.32e-06	0.000104	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NCOA2—prostate cancer	6.26e-06	0.000103	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.25e-06	0.000103	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SULT2A1—prostate cancer	6.17e-06	0.000101	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—HPGDS—prostate cancer	6.16e-06	0.000101	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PIK3CD—prostate cancer	6.13e-06	0.0001	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP2C19—prostate cancer	6.12e-06	0.0001	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—TNFRSF21—prostate cancer	6.07e-06	9.95e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—MED12—prostate cancer	6.07e-06	9.94e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—SERPINE1—prostate cancer	6.06e-06	9.94e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GNG5—prostate cancer	6.02e-06	9.87e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTT1—prostate cancer	5.98e-06	9.8e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ACHE—prostate cancer	5.98e-06	9.8e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—SLC5A5—prostate cancer	5.97e-06	9.79e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP2A6—prostate cancer	5.91e-06	9.68e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—MTAP—prostate cancer	5.9e-06	9.68e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP7B1—prostate cancer	5.9e-06	9.68e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.88e-06	9.65e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP2E1—prostate cancer	5.83e-06	9.56e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NCOA3—prostate cancer	5.8e-06	9.5e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—NOS3—prostate cancer	5.79e-06	9.49e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NQO1—prostate cancer	5.77e-06	9.45e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SULT1E1—prostate cancer	5.75e-06	9.43e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SRD5A1—prostate cancer	5.75e-06	9.43e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—AKR1C3—prostate cancer	5.75e-06	9.42e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PRKACB—prostate cancer	5.72e-06	9.37e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.7e-06	9.34e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—TH—prostate cancer	5.68e-06	9.32e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP17A1—prostate cancer	5.66e-06	9.27e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—JAK2—prostate cancer	5.62e-06	9.22e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP3A4—prostate cancer	5.62e-06	9.22e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.59e-06	9.17e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.58e-06	9.15e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—HPGDS—prostate cancer	5.53e-06	9.07e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP1B1—prostate cancer	5.53e-06	9.06e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HSD17B3—prostate cancer	5.49e-06	9e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ACSL4—prostate cancer	5.49e-06	9e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NCOA2—prostate cancer	5.39e-06	8.84e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTT1—prostate cancer	5.36e-06	8.79e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ACHE—prostate cancer	5.36e-06	8.79e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GGT1—prostate cancer	5.35e-06	8.78e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PIK3CB—prostate cancer	5.34e-06	8.76e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP2A6—prostate cancer	5.3e-06	8.69e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.28e-06	8.66e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NCOA1—prostate cancer	5.27e-06	8.65e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PHGDH—prostate cancer	5.26e-06	8.63e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—UMPS—prostate cancer	5.26e-06	8.63e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ARG2—prostate cancer	5.26e-06	8.63e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP19A1—prostate cancer	5.2e-06	8.52e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—LDHB—prostate cancer	5.16e-06	8.46e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	5.16e-06	8.46e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—AKR1C3—prostate cancer	5.16e-06	8.46e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SLC5A5—prostate cancer	5.14e-06	8.43e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PRKACB—prostate cancer	5.13e-06	8.41e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP17A1—prostate cancer	5.08e-06	8.32e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP3A5—prostate cancer	5.07e-06	8.3e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP2E1—prostate cancer	5.02e-06	8.23e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—RXRA—prostate cancer	5.02e-06	8.22e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.01e-06	8.21e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NQO1—prostate cancer	4.97e-06	8.14e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IL2—prostate cancer	4.91e-06	8.04e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—TH—prostate cancer	4.89e-06	8.02e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PDHA1—prostate cancer	4.89e-06	8.02e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTA3—prostate cancer	4.89e-06	8.02e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—UCP3—prostate cancer	4.89e-06	8.02e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—TCN2—prostate cancer	4.89e-06	8.02e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.86e-06	7.97e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP3A4—prostate cancer	4.84e-06	7.94e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NCOA2—prostate cancer	4.84e-06	7.93e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—COMT—prostate cancer	4.83e-06	7.92e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.82e-06	7.9e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTP1—prostate cancer	4.81e-06	7.88e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP1B1—prostate cancer	4.76e-06	7.81e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ITPR1—prostate cancer	4.73e-06	7.76e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.67e-06	7.65e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.67e-06	7.65e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SLC5A5—prostate cancer	4.62e-06	7.57e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GGT1—prostate cancer	4.61e-06	7.56e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NCOA1—prostate cancer	4.54e-06	7.45e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP2E1—prostate cancer	4.51e-06	7.39e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP19A1—prostate cancer	4.48e-06	7.34e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTA4—prostate cancer	4.47e-06	7.34e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—TBXAS1—prostate cancer	4.47e-06	7.34e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—TYMS—prostate cancer	4.47e-06	7.33e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NQO1—prostate cancer	4.46e-06	7.31e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTM1—prostate cancer	4.42e-06	7.25e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—EP300—prostate cancer	4.4e-06	7.22e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—TH—prostate cancer	4.39e-06	7.2e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.37e-06	7.16e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTA2—prostate cancer	4.36e-06	7.15e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP3A4—prostate cancer	4.35e-06	7.13e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—LPL—prostate cancer	4.34e-06	7.11e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.33e-06	7.09e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—RXRA—prostate cancer	4.32e-06	7.08e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SULT1A1—prostate cancer	4.31e-06	7.06e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ABCG5—prostate cancer	4.31e-06	7.06e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—SRC—prostate cancer	4.28e-06	7.02e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP1B1—prostate cancer	4.27e-06	7.01e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTA1—prostate cancer	4.21e-06	6.9e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.2e-06	6.89e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP1A1—prostate cancer	4.19e-06	6.87e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—VEGFA—prostate cancer	4.17e-06	6.83e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—COMT—prostate cancer	4.16e-06	6.82e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HSD3B2—prostate cancer	4.16e-06	6.82e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTO1—prostate cancer	4.16e-06	6.82e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NAT2—prostate cancer	4.16e-06	6.82e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ERCC2—prostate cancer	4.16e-06	6.81e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTP1—prostate cancer	4.14e-06	6.79e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GGT1—prostate cancer	4.14e-06	6.79e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NCOA1—prostate cancer	4.08e-06	6.68e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ITPR1—prostate cancer	4.08e-06	6.68e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP19A1—prostate cancer	4.02e-06	6.59e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.01e-06	6.57e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PLCB2—prostate cancer	3.99e-06	6.54e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.99e-06	6.54e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—LRP2—prostate cancer	3.99e-06	6.54e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—P4HB—prostate cancer	3.91e-06	6.41e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—MTHFR—prostate cancer	3.91e-06	6.4e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—RXRA—prostate cancer	3.88e-06	6.36e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—TYMS—prostate cancer	3.85e-06	6.31e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PPARA—prostate cancer	3.83e-06	6.28e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—TGFB1—prostate cancer	3.83e-06	6.27e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTM1—prostate cancer	3.81e-06	6.24e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.8e-06	6.24e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.77e-06	6.18e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—LPL—prostate cancer	3.74e-06	6.12e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—COMT—prostate cancer	3.74e-06	6.12e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTP1—prostate cancer	3.72e-06	6.1e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.71e-06	6.08e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ITPR1—prostate cancer	3.66e-06	6e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—MED12—prostate cancer	3.65e-06	5.98e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GNG5—prostate cancer	3.62e-06	5.93e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP1A1—prostate cancer	3.61e-06	5.92e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CAV1—prostate cancer	3.6e-06	5.91e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.6e-06	5.9e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ERCC2—prostate cancer	3.58e-06	5.87e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—KRAS—prostate cancer	3.54e-06	5.81e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NCOA3—prostate cancer	3.49e-06	5.72e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—TYMS—prostate cancer	3.46e-06	5.67e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTM1—prostate cancer	3.42e-06	5.6e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—MTHFR—prostate cancer	3.36e-06	5.51e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—LPL—prostate cancer	3.35e-06	5.5e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HPGDS—prostate cancer	3.33e-06	5.45e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.3e-06	5.42e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PPARA—prostate cancer	3.3e-06	5.41e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CG—prostate cancer	3.28e-06	5.38e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PIK3CA—prostate cancer	3.26e-06	5.34e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP1A1—prostate cancer	3.24e-06	5.31e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTT1—prostate cancer	3.23e-06	5.29e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ACHE—prostate cancer	3.23e-06	5.29e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ERCC2—prostate cancer	3.21e-06	5.27e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.19e-06	5.23e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—TP53—prostate cancer	3.15e-06	5.16e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—INS—prostate cancer	3.11e-06	5.09e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CAV1—prostate cancer	3.1e-06	5.09e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.1e-06	5.08e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PRKACB—prostate cancer	3.09e-06	5.06e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.05e-06	5.01e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CREBBP—prostate cancer	3.04e-06	4.99e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—MTHFR—prostate cancer	3.02e-06	4.95e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.96e-06	4.86e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PPARA—prostate cancer	2.96e-06	4.86e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NCOA2—prostate cancer	2.91e-06	4.77e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CD—prostate cancer	2.88e-06	4.73e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CG—prostate cancer	2.83e-06	4.63e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CAV1—prostate cancer	2.79e-06	4.57e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.78e-06	4.55e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NOS3—prostate cancer	2.72e-06	4.47e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.71e-06	4.44e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NQO1—prostate cancer	2.68e-06	4.39e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—INS—prostate cancer	2.68e-06	4.39e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.66e-06	4.36e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—AKT1—prostate cancer	2.66e-06	4.36e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—TH—prostate cancer	2.64e-06	4.33e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CREBBP—prostate cancer	2.62e-06	4.3e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.57e-06	4.21e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CG—prostate cancer	2.54e-06	4.16e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CB—prostate cancer	2.51e-06	4.12e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PTGS2—prostate cancer	2.49e-06	4.08e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GGT1—prostate cancer	2.49e-06	4.08e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CD—prostate cancer	2.48e-06	4.07e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NCOA1—prostate cancer	2.45e-06	4.02e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.42e-06	3.96e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—INS—prostate cancer	2.4e-06	3.94e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CREBBP—prostate cancer	2.35e-06	3.86e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NOS3—prostate cancer	2.35e-06	3.85e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—RXRA—prostate cancer	2.33e-06	3.82e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—COMT—prostate cancer	2.25e-06	3.68e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTP1—prostate cancer	2.24e-06	3.67e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CD—prostate cancer	2.23e-06	3.66e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ITPR1—prostate cancer	2.2e-06	3.61e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PTEN—prostate cancer	2.17e-06	3.56e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CB—prostate cancer	2.17e-06	3.55e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PTGS2—prostate cancer	2.15e-06	3.52e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NOS3—prostate cancer	2.11e-06	3.45e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—TYMS—prostate cancer	2.08e-06	3.41e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—EP300—prostate cancer	2.07e-06	3.4e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTM1—prostate cancer	2.05e-06	3.37e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—LPL—prostate cancer	2.02e-06	3.31e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.95e-06	3.19e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.94e-06	3.19e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.93e-06	3.17e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PTGS2—prostate cancer	1.93e-06	3.16e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PTEN—prostate cancer	1.87e-06	3.07e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.82e-06	2.98e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—EP300—prostate cancer	1.78e-06	2.93e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PPARA—prostate cancer	1.78e-06	2.92e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PTEN—prostate cancer	1.68e-06	2.75e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CAV1—prostate cancer	1.67e-06	2.75e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—EP300—prostate cancer	1.6e-06	2.63e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.53e-06	2.51e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.53e-06	2.5e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—INS—prostate cancer	1.44e-06	2.37e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CREBBP—prostate cancer	1.41e-06	2.32e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.34e-06	2.2e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CA—prostate cancer	1.32e-06	2.16e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NOS3—prostate cancer	1.27e-06	2.08e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—AKT1—prostate cancer	1.25e-06	2.05e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.19e-06	1.94e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.17e-06	1.92e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PTGS2—prostate cancer	1.16e-06	1.9e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—AKT1—prostate cancer	1.08e-06	1.77e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PTEN—prostate cancer	1.01e-06	1.66e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—AKT1—prostate cancer	9.68e-07	1.59e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—EP300—prostate cancer	9.63e-07	1.58e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CA—prostate cancer	7.13e-07	1.17e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—AKT1—prostate cancer	5.82e-07	9.54e-06	CbGpPWpGaD
